J Virol. 1997 Aug;71(8):6174-8.

Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation.

Takeuchi Y, Liong SH, Bieniasz PD, Jäger U, Porter CD, Friedman T, McClure MO, Weiss RA.

Source

Chester Beatty Laboratories, Institute of Cancer Research, London, England. yasuhiro@icr.ac.uk

Abstract

Vesicular stomatitis virus, human immunodeficiency virus type 2, and human foamy virus, which were produced by cell lines expressing galactosyl(alpha1-3)galactosyl (alphaGal) sugars, were found to be less stable in human serum than those from alphaGal-negative cells, indicating that galactosyl(alpha1-3)galactosylation sensitizes these viruses as well as mammalian type C oncoviruses (Rother et al., J. Exp. Med. 182:1345-1355, 1995; Takeuchi et al., Nature (London) 379:85-88, 1996) to complement killing via natural anti-alphaGal antibodies. Thus, virus killing mediated by anti-alphaGal antibodies may play a role as a barrier to animal-to-human infection of various enveloped viruses. Virus vectors for human in vivo gene therapy based on the viruses mentioned above should be produced from alphaGal-negative cells.

PMID:: 9223512; [PubMed - indexed for MEDLINE]
PMCID:: PMC191878

Free PMC Article

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Blood - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. [J Exp Med. 1995]
A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.
Rother RP, Fodor WL, Springhorn JP, Birks CW, Setter E, Sandrin MS, Squinto SP, Rollins SA. J Exp Med. 1995 Nov 1; 182(5):1345-55.
Human serum-resistant retroviral vector particles from galactosyl (alpha1-3) galactosyl containing nonprimate cell lines. [Gene Ther. 1999]
Human serum-resistant retroviral vector particles from galactosyl (alpha1-3) galactosyl containing nonprimate cell lines.
Mason JM, Guzowski DE, Goodwin LO, Porti D, Cronin KC, Teichberg S, Pergolizzi RG. Gene Ther. 1999 Aug; 6(8):1397-405.
Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. [Virology. 2000]
Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
Haglund K, Forman J, Kräusslich HG, Rose JK. Virology. 2000 Mar 1; 268(1):112-21.
Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope. [J Virol. 2004]
Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope.
Magre S, Takeuchi Y, Langford G, Richards A, Patience C, Weiss R. J Virol. 2004 Jun; 78(11):5812-9.
Packaging cell lines for simian foamy virus type 1 vectors. [J Virol. 1999]
Packaging cell lines for simian foamy virus type 1 vectors.
Wu M, Mergia A. J Virol. 1999 May; 73(5):4498-501.

See reviews... See all...

Cited by 11 PubMed Central articles

Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64. [J Virol. 2010]
Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64.
Kaname Y, Tani H, Kataoka C, Shiokawa M, Taguwa S, Abe T, Moriishi K, Kinoshita T, Matsuura Y. J Virol. 2010 Apr; 84(7):3210-9. Epub 2010 Jan 13.
Review Foamy virus vectors for gene transfer. [Expert Opin Biol Ther. 2009]
Review Foamy virus vectors for gene transfer.
Trobridge GD. Expert Opin Biol Ther. 2009 Nov; 9(11):1427-36.
Review Cross-species virus transmission and the emergence of new epidemic diseases. [Microbiol Mol Biol Rev. 2008]
Review Cross-species virus transmission and the emergence of new epidemic diseases.
Parrish CR, Holmes EC, Morens DM, Park EC, Burke DS, Calisher CH, Laughlin CA, Saif LJ, Daszak P. Microbiol Mol Biol Rev. 2008 Sep; 72(3):457-70.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(...
Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation.
J Virol. 1997 Aug ;71(8):6174-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: